Platelets from Bleeding Simmental Cattle Have a Long Delay in both ADP-activated Expression of GpllB-IIIA Receptors and Fibrinogen-dependent Platelet Aggregation

Summary

We have previously reported that platelets from bleeding Simmental cattle do not aggregate in vitro in response to ADP, collagen and calcium ionophore A23187, though calcium mobilization and myosin light chain phosphorylation do occur. The aggregation abnormality, measured by aggregometry, was ascribed to abnormal cytoskeletal expression, with the maximal numbers of activated GpIIb-IIIa receptors per platelet no different from that seen in normal bovine platelets activated with ADP. We have therefore sought to compare the kinetics of microaggregation with the rate of expression of GpIIb-IIIa receptors required for mediating fibrinogen (Fg)-dependent platelet aggregation, to provide a more direct molecular explanation for the aggregation abnormality. We compared aggregation kinetics of ADP-activated platelets using both aggregometry and particle counting to monitor microaggregation. Fibrinogen receptor expression was monitored with FITC-labelled human Fg and with the reporting antibody for activated GpIIb-IIIa, FITC-PAC1, using flow cytometry. The affected platelets show a marked delay in onset of microaggregation for ADP-activated platelets stirred with human Fg, paralleded by an unusual delay in activated GpIIb-IIIa receptor expression (DARE) for otherwise competent Fg binding. The on-rates for Fg binding to platelets maximally pre-activat-ed with PMA are identical for normal and affected platelets, whether comparing the binding of human or bovine Fg. The unique DARE syndrome explains the observed delay in aggregation of platelets from affected Simmental cattle and predicts the bleeding problems due to delayed binding of adhesive proteins.

• References

• 1 Searcy GP, Frojmovic MM, McNicol A, Robertson C, Wong T, Gerrard John M. Platelets from bleeding Simmental cattle mobilize calcium, phosphorylate myosin light chain and bind normal numbers of fibrinogen molecules but have abnormal cytoskeletal assembly and aggregation in response to ADP. Thromb Haemost 1994; 71: 240-246
• 2 Searcy GP, Petrie L. Clinical and laboratory findings of a bleeding disorder in Simmental cattle. Can Vet J 1990; 31: 101-113
• 3 Searcy GP, Sheridan D, Dobson KA. Preliminary studies of a platelet function disorder in Simmental cattle. Can J Vet Res 1990; 54: 394-396
• 4 Frojmovic MM, Milton J, Gear A. Platelet aggregation measured in vitro by microscopic and electronic particle counting methods. Methods Enzymol 1989; 169: 134-139
• 5 Frojmovic MM, Mooney RM, Wong T. Dynamics of platelet glycoprotein Ilb-IIIa receptor expression and fibrinogen binding II. Quantal activation parallels platelet capture in stirdependent microaggregation. Biophys J 1994; 67: 2069-2075
• 6 Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein Ilb-IIIa complex. Blood 1988; 71: 831-843
• 7 Frojmovic MM, van de Ven T. Dynamic measurements of the platelet membrane glycoprotein Ilb-IIIa receptor for fibrinogen by flow cytometry: I. Methodology, theory, and results for two distinct activators. Biophys J 1991; 59: 815-827
• 8 Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987; 70: 307-315
• 9 Xia Z, Frojmovic MM. Aggregation efficiency of activated normal or fixed platelets in a simple shear field: Effect of shear and fibrinogen occupancy. Biophys J 1994; 66: 2190-2201
• 10 Xia Z, Wong T, Liu Q, Kasirer-Friede A, Brown E, Frojmovic MM. Optimally-functional fluorescein isothiocyanate (FITC)-labelled fibrinogen for quantitative studies of binding to activated platelets and platelet aggregation. Br J Haematol 1996; 93: 204-214
• 11 Frelinger ALIII, Cohen I, Plow EF, Smith MA, Roberts J, Lam SC-T, Ginsberg MH. Selective inhibition of integrin function by antibodies specific for ligand-occupied . receptor conformers. J Biol Chem 1990; 265: 6346-6352
• 12 Frojmovic MM, Mooney RM, Wong T. Dynamics of platelet glycoprotein Ilb-IIIa receptor expression and fibrinogen binding I. Quantal activation of platelet subpopulations varies with adenosine diphosphate concentration. Biophys J 1994; 67: 2060-2068
• 13 Ugarova TP, Budzynski AZ, Shattil SJ, Ruggeri ZM, Ginsberg MH, Plow EF. Conformational changes in fibrinogen elicited by its interaction with platelet membrane glycoprotein Ilb-IIIa. J Biol Chem 1993; 268: 21080-21087
• 14 Ginsberg MH, Frelinger AL, Lam SCT, Forsyth J, McMillan R, Plow EF, Shattil SJ. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein Ilb-IIIa with conformation-specific monoclonal antibodies. Blood 1990; 76: 2017-2023
• 15 Ginsberg MH, Lightsey A, Kunicki TJ, Kaufman A, Marguerie GA, Plow EF. Divalent cation regulation of the surface orientation of platelet membrane glycoprotein lib: Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann,s thrombasthenia. J Clin Invest 1986; 78: 1103-1111
• 16 Chen Y-P, Djaffar I, Pidard D, Steiner B, Cieutat A-M, Caen JP, Rosa J-P. Ser-752 → Pro mutation in the cytoplasmic domain of integrin β₃ subunit and defective activation of platelet integrin α^IIbβ₃ (glycoprotein Ilb-IIIa) in a variant of Glanzmann thrombasthenia. Proc Natl Acad Sci USA 1992; 89: 10169-10173
• 17 Sullivan PS, Grubbs ST, Olchowy TWJ, Andrews FM, White JG, Catalfamo JL, Dodd PA, McDonald TP. Bleeding diathesis associated with variant von Willebrand factor in a Simmental calf. J Am Vet Med Assoc 1994; 205: 1763-1766
• 18 Ruggeri ZM. Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haemost 1993; 70: 119-123
• 19 Plow EF, Pierschbacher MD, Ruoslahti E, Marguerie G, Ginsberg MH. The effect of ARG-GLY-ASP-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci USA 1985; 82: 8057-8061
• 20 Pietu G, Cherel G, Marguerie G, Meyer D. Inhibition of von Willebrand factor-plate-let interaction by fibrinogen. Nature 1984; 308: 648-649